Guginski Giselle, Luiz Ana Paula, Silva Morgana Duarte, Massaro Murilo, Martins Daniel Fernandes, Chaves Juliana, Mattos Robson Willain, Silveira Damaris, Ferreira Vânia M M, Calixto João Batista, Santos Adair R S
Departamento de Farmacologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Campus Universitário, Trindade, Florianópolis, 88049-000, SC, Brazil.
Pharmacol Biochem Behav. 2009 Jul;93(1):10-6. doi: 10.1016/j.pbb.2009.03.014. Epub 2009 Apr 7.
The present study examined the antinociceptive effect of the ethanolic extract from Melissa officinalis L. and of the rosmarinic acid in chemical behavioral models of nociception and investigates some of the mechanisms underlying this effect. The extract (3-1000 mg/kg), given orally (p.o.) 1 h prior to testing, produced dose-dependent inhibition of acetic acid-induced visceral pain, with ID50 value of 241.9 mg/kg. In the formalin test, the extract (30-1000 mg/kg, p.o.) also caused significant inhibition of both, the early (neurogenic pain) and the late (inflammatory pain), phases of formalin-induced licking. The extract (10-1000 mg/kg, p.o.) also caused significant and dose-dependent inhibition of glutamate-induced pain, with ID50 value of 198.5 mg/kg. Furthermore, the rosmarinic acid (0.3-3 mg/kg), given p.o. 1 h prior, produced dose-related inhibition of glutamate-induced pain, with ID50 value of 2.64 mg/kg. The antinociception caused by the extract (100 mg/kg, p.o.) in the glutamate test was significantly attenuated by intraperitoneal (i.p.) treatment of mice with atropine (1 mg/kg), mecamylamine (2 mg/kg) or l-arginine (40 mg/kg). In contrast, the extract (100 mg/kg, p.o.) antinociception was not affected by i.p. treatment with naloxone (1 mg/kg) or D-arginine (40 mg/kg). It was also not associated with non-specific effects, such as muscle relaxation or sedation. Collectively, the present results suggest that the extract produced dose-related antinociception in several models of chemical pain through mechanisms that involved cholinergic systems (i.e. through muscarinic and nicotinic acetylcholine receptors) and the L-arginine-nitric oxide pathway. In addition, the rosmarinic acid contained in this plant appears to contribute for the antinociceptive property of the extract. Moreover, the antinociceptive action demonstrated in the present study supports, at least partly, the ethnomedical uses of this plant.
本研究在伤害感受的化学行为模型中检测了蜜蜂花乙醇提取物和迷迭香酸的抗伤害感受作用,并探究了这种作用的一些潜在机制。提取物(3 - 1000毫克/千克)在测试前1小时口服给药,对醋酸诱导的内脏疼痛产生剂量依赖性抑制,半数抑制剂量(ID50)值为241.9毫克/千克。在福尔马林试验中,提取物(30 - 1000毫克/千克,口服)对福尔马林诱导的舔舐行为的早期(神经源性疼痛)和晚期(炎症性疼痛)阶段均产生显著抑制。提取物(10 - 1000毫克/千克,口服)对谷氨酸诱导的疼痛也产生显著的剂量依赖性抑制,ID50值为198.5毫克/千克。此外,迷迭香酸(0.3 - 3毫克/千克)在给药前1小时口服,对谷氨酸诱导的疼痛产生剂量相关的抑制,ID50值为2.64毫克/千克。在谷氨酸试验中,提取物(100毫克/千克,口服)引起的抗伤害感受作用在小鼠腹腔注射阿托品(1毫克/千克)、美加明(2毫克/千克)或L - 精氨酸(40毫克/千克)后显著减弱。相反,提取物(100毫克/千克,口服)的抗伤害感受作用不受腹腔注射纳洛酮(1毫克/千克)或D - 精氨酸(40毫克/千克)的影响。它也与非特异性作用无关,如肌肉松弛或镇静作用。总体而言,目前的结果表明,提取物通过涉及胆碱能系统(即通过毒蕈碱型和烟碱型乙酰胆碱受体)和L - 精氨酸 - 一氧化氮途径的机制,在几种化学疼痛模型中产生剂量相关的抗伤害感受作用。此外,该植物中含有的迷迭香酸似乎有助于提取物的抗伤害感受特性。而且,本研究中证明的抗伤害感受作用至少部分支持了这种植物的民族医学用途。